Research Projects & Grants

For Profit Organization

• A Phase I, Randomized, Open-Label, Active Controlled, Multi-Center Pilot Study to Compare Reference to Reference Pharmacodynamics of BOTOX® (onabotulinumtoxinA) in Healthy Subjects. Protocol: MR 103A-0I-IPS-1001. lnformed Consent Form Version Dated 25 November 2022., Role: Investigator, Mylan Pharmaceuticals, (11/2023 - 03/2024) Status: Completed
• A phase 2, randomized, double-blind, placebo-controlled parallel group study ofVHB937 in Amyotrophic Lateral Sclerosis (ALS) over 40 weeks followed by an Open-label Extension (ASTRALS). Protocol: CVHB937B12201, Role: Investigator, Novartis Pharmaceuticals Corporation, (03/2026 - 03/2027) Status: Approved
• A Randomized, Double-Blinded, Placebo-Controlled, Phase 3, Parallel-Group Design Study Evaluating the Efficacy and Safety of Efgartigimod PH20 SC Administered by Prefilled Syringe in Adult Participants With Ocular Myasthenia Gravis., Role: Investigator, Argenx BV, (02/2026 - 02/2027) Status: Approved